Betta Pharmaceuticals Co., Ltd. (SHE:300558)
China flag China · Delayed Price · Currency is CNY
51.18
+1.19 (2.38%)
Apr 25, 2025, 2:45 PM CST

Betta Pharmaceuticals Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Jan '22 Dec '20 2015 - 2019
Cash & Equivalents
471.68752731.28791.991,346
Upgrade
Short-Term Investments
----190
Upgrade
Trading Asset Securities
126.440.54-201.01-
Upgrade
Cash & Short-Term Investments
598.12752.54731.289931,536
Upgrade
Cash Growth
-20.52%2.91%-26.36%-35.35%194.64%
Upgrade
Accounts Receivable
98.47286.41450.62173.3852.61
Upgrade
Other Receivables
1.832.6149.740.756.81
Upgrade
Receivables
100.3289.02500.32214.1359.42
Upgrade
Inventory
290.09327.5372.17293.32188.59
Upgrade
Prepaid Expenses
-0.2---
Upgrade
Other Current Assets
235.82156.62129.06153.4963.91
Upgrade
Total Current Assets
1,2241,5261,7331,6541,848
Upgrade
Property, Plant & Equipment
3,0092,5742,0561,331775.72
Upgrade
Long-Term Investments
1,4371,382919.27345.79274.55
Upgrade
Goodwill
413.58413.58413.58413.58413.58
Upgrade
Other Intangible Assets
2,7761,9441,2191,183603.37
Upgrade
Long-Term Deferred Tax Assets
56.7339.1385.9655.0655.22
Upgrade
Long-Term Deferred Charges
383.531,2191,4441,2521,171
Upgrade
Other Long-Term Assets
41.9950.339.337.687.79
Upgrade
Total Assets
9,3429,1477,9106,2715,230
Upgrade
Accounts Payable
746.11800.1235.85431.19113.62
Upgrade
Accrued Expenses
285.53357.82419.11357.02187.53
Upgrade
Short-Term Debt
100.08300.27380.39--
Upgrade
Current Portion of Long-Term Debt
639.85301.25---
Upgrade
Current Portion of Leases
33.034.64.164.88-
Upgrade
Current Income Taxes Payable
4.260.070.0410.6827.54
Upgrade
Current Unearned Revenue
2.634.924.460.691.27
Upgrade
Other Current Liabilities
36.4734.111,26184.4108.14
Upgrade
Total Current Liabilities
1,8481,8032,105888.86438.1
Upgrade
Long-Term Debt
1,5521,816656.03-2.6
Upgrade
Long-Term Leases
71.638.187.36.34-
Upgrade
Long-Term Unearned Revenue
150.99144.7112.7611258.01
Upgrade
Long-Term Deferred Tax Liabilities
53.4923.3971.5768.3964.64
Upgrade
Other Long-Term Liabilities
---510.06521.99
Upgrade
Total Liabilities
3,6763,7952,9521,5861,085
Upgrade
Common Stock
418.49418.49417.47415.39413.16
Upgrade
Additional Paid-In Capital
1,9451,9451,8601,9321,793
Upgrade
Retained Earnings
2,8342,5032,1812,1391,883
Upgrade
Comprehensive Income & Other
375.78384.48390.9974.6452.28
Upgrade
Total Common Equity
5,5745,2514,8494,5614,141
Upgrade
Minority Interest
92.3100.4108.64124.93.41
Upgrade
Shareholders' Equity
5,6665,3514,9584,6864,144
Upgrade
Total Liabilities & Equity
9,3429,1477,9106,2715,230
Upgrade
Total Debt
2,3962,4301,04811.222.6
Upgrade
Net Cash (Debt)
-1,798-1,678-316.59981.771,533
Upgrade
Net Cash Growth
----35.97%-
Upgrade
Net Cash Per Share
-4.29-4.00-0.762.363.77
Upgrade
Filing Date Shares Outstanding
418.49418.49417.47415.39413.16
Upgrade
Total Common Shares Outstanding
418.49418.49417.47415.39413.16
Upgrade
Working Capital
-623.63-277.28-371.95765.081,410
Upgrade
Book Value Per Share
13.3212.5511.6210.9810.02
Upgrade
Tangible Book Value
2,3842,8943,2162,9643,124
Upgrade
Tangible Book Value Per Share
5.706.927.707.147.56
Upgrade
Buildings
2,952586.14585.59627.19588.32
Upgrade
Machinery
449.64424.26402.25376.01339.24
Upgrade
Construction In Progress
191.872,0371,448639.6763.12
Upgrade
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.